Found 69 hits with Last Name = 'malmström' and Initial = 'j' Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Mitogen-activated protein kinase 10
(Homo sapiens (Human)) | BDBM50172920
(3-(6-(2-chlorophenylamino)-1H-indazol-3-yl)-N-(pip...)Show SMILES Clc1ccccc1Nc1ccc2c(n[nH]c2c1)-c1cccc(c1)C(=O)NC1CCNCC1 Show InChI InChI=1S/C25H24ClN5O/c26-21-6-1-2-7-22(21)28-19-8-9-20-23(15-19)30-31-24(20)16-4-3-5-17(14-16)25(32)29-18-10-12-27-13-11-18/h1-9,14-15,18,27-28H,10-13H2,(H,29,32)(H,30,31) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 1.40 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D Södertälje
Curated by ChEMBL
| Assay Description Inhibitory concentration against c-Jun N-terminal kinase 3 |
Bioorg Med Chem Lett 15: 5095-9 (2005)
Article DOI: 10.1016/j.bmcl.2005.06.083 BindingDB Entry DOI: 10.7270/Q2JW8DFC |
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 10
(Homo sapiens (Human)) | BDBM50211306
(4-(6-(2-chlorophenylamino)-1H-indazol-3-yl)-N-(2-(...)Show SMILES CN(C)CCNC(=O)c1ccc(cc1)-c1n[nH]c2cc(Nc3ccccc3Cl)ccc12 Show InChI InChI=1S/C24H24ClN5O/c1-30(2)14-13-26-24(31)17-9-7-16(8-10-17)23-19-12-11-18(15-22(19)28-29-23)27-21-6-4-3-5-20(21)25/h3-12,15,27H,13-14H2,1-2H3,(H,26,31)(H,28,29) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 1.90 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D Södertälje
Curated by ChEMBL
| Assay Description Inhibitory concentration against c-Jun N-terminal kinase 3 |
Bioorg Med Chem Lett 15: 5095-9 (2005)
Article DOI: 10.1016/j.bmcl.2005.06.083 BindingDB Entry DOI: 10.7270/Q2JW8DFC |
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 14
(Homo sapiens (Human)) | BDBM50172919
(3-[6-(2-Chloro-phenylamino)-1H-indazol-3-yl]-benza...)Show SMILES NC(=O)c1cccc(c1)-c1n[nH]c2cc(Nc3ccccc3Cl)ccc12 Show InChI InChI=1S/C20H15ClN4O/c21-16-6-1-2-7-17(16)23-14-8-9-15-18(11-14)24-25-19(15)12-4-3-5-13(10-12)20(22)26/h1-11,23H,(H2,22,26)(H,24,25) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 3.20 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D Södertälje
Curated by ChEMBL
| Assay Description Inhibitory concentration against Mitogen-activated protein kinase p38 alpha |
Bioorg Med Chem Lett 15: 5095-9 (2005)
Article DOI: 10.1016/j.bmcl.2005.06.083 BindingDB Entry DOI: 10.7270/Q2JW8DFC |
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 10
(Homo sapiens (Human)) | BDBM50172919
(3-[6-(2-Chloro-phenylamino)-1H-indazol-3-yl]-benza...)Show SMILES NC(=O)c1cccc(c1)-c1n[nH]c2cc(Nc3ccccc3Cl)ccc12 Show InChI InChI=1S/C20H15ClN4O/c21-16-6-1-2-7-17(16)23-14-8-9-15-18(11-14)24-25-19(15)12-4-3-5-13(10-12)20(22)26/h1-11,23H,(H2,22,26)(H,24,25) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 3.30 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D Södertälje
Curated by ChEMBL
| Assay Description Inhibitory concentration against c-Jun N-terminal kinase 3 |
Bioorg Med Chem Lett 15: 5095-9 (2005)
Article DOI: 10.1016/j.bmcl.2005.06.083 BindingDB Entry DOI: 10.7270/Q2JW8DFC |
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 10
(Homo sapiens (Human)) | BDBM50172921
(3-[6-(2-Chloro-phenylamino)-1H-indazol-3-yl]-N-(3-...)Show SMILES Clc1ccccc1Nc1ccc2c(n[nH]c2c1)-c1cccc(c1)C(=O)NCCCN1CCOCC1 Show InChI InChI=1S/C27H28ClN5O2/c28-23-7-1-2-8-24(23)30-21-9-10-22-25(18-21)31-32-26(22)19-5-3-6-20(17-19)27(34)29-11-4-12-33-13-15-35-16-14-33/h1-3,5-10,17-18,30H,4,11-16H2,(H,29,34)(H,31,32) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 3.40 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D Södertälje
Curated by ChEMBL
| Assay Description Inhibitory concentration against c-Jun N-terminal kinase 3 |
Bioorg Med Chem Lett 15: 5095-9 (2005)
Article DOI: 10.1016/j.bmcl.2005.06.083 BindingDB Entry DOI: 10.7270/Q2JW8DFC |
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 14
(Homo sapiens (Human)) | BDBM50172921
(3-[6-(2-Chloro-phenylamino)-1H-indazol-3-yl]-N-(3-...)Show SMILES Clc1ccccc1Nc1ccc2c(n[nH]c2c1)-c1cccc(c1)C(=O)NCCCN1CCOCC1 Show InChI InChI=1S/C27H28ClN5O2/c28-23-7-1-2-8-24(23)30-21-9-10-22-25(18-21)31-32-26(22)19-5-3-6-20(17-19)27(34)29-11-4-12-33-13-15-35-16-14-33/h1-3,5-10,17-18,30H,4,11-16H2,(H,29,34)(H,31,32) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 3.70 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D Södertälje
Curated by ChEMBL
| Assay Description Inhibitory concentration against Mitogen-activated protein kinase p38 alpha |
Bioorg Med Chem Lett 15: 5095-9 (2005)
Article DOI: 10.1016/j.bmcl.2005.06.083 BindingDB Entry DOI: 10.7270/Q2JW8DFC |
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 14
(Homo sapiens (Human)) | BDBM50172920
(3-(6-(2-chlorophenylamino)-1H-indazol-3-yl)-N-(pip...)Show SMILES Clc1ccccc1Nc1ccc2c(n[nH]c2c1)-c1cccc(c1)C(=O)NC1CCNCC1 Show InChI InChI=1S/C25H24ClN5O/c26-21-6-1-2-7-22(21)28-19-8-9-20-23(15-19)30-31-24(20)16-4-3-5-17(14-16)25(32)29-18-10-12-27-13-11-18/h1-9,14-15,18,27-28H,10-13H2,(H,29,32)(H,30,31) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 4.40 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D Södertälje
Curated by ChEMBL
| Assay Description Inhibitory concentration against Mitogen-activated protein kinase p38 alpha |
Bioorg Med Chem Lett 15: 5095-9 (2005)
Article DOI: 10.1016/j.bmcl.2005.06.083 BindingDB Entry DOI: 10.7270/Q2JW8DFC |
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 10
(Homo sapiens (Human)) | BDBM50172927
(3-[6-(2-Chloro-phenylamino)-1H-indazol-3-yl]-benzo...)Show SMILES OC(=O)c1cccc(c1)-c1n[nH]c2cc(Nc3ccccc3Cl)ccc12 Show InChI InChI=1S/C20H14ClN3O2/c21-16-6-1-2-7-17(16)22-14-8-9-15-18(11-14)23-24-19(15)12-4-3-5-13(10-12)20(25)26/h1-11,22H,(H,23,24)(H,25,26) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 5.30 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D Södertälje
Curated by ChEMBL
| Assay Description Inhibitory concentration against c-Jun N-terminal kinase 3 |
Bioorg Med Chem Lett 15: 5095-9 (2005)
Article DOI: 10.1016/j.bmcl.2005.06.083 BindingDB Entry DOI: 10.7270/Q2JW8DFC |
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 14
(Homo sapiens (Human)) | BDBM50211306
(4-(6-(2-chlorophenylamino)-1H-indazol-3-yl)-N-(2-(...)Show SMILES CN(C)CCNC(=O)c1ccc(cc1)-c1n[nH]c2cc(Nc3ccccc3Cl)ccc12 Show InChI InChI=1S/C24H24ClN5O/c1-30(2)14-13-26-24(31)17-9-7-16(8-10-17)23-19-12-11-18(15-22(19)28-29-23)27-21-6-4-3-5-20(21)25/h3-12,15,27H,13-14H2,1-2H3,(H,26,31)(H,28,29) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 8.70 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D Södertälje
Curated by ChEMBL
| Assay Description Inhibitory concentration against Mitogen-activated protein kinase p38 alpha |
Bioorg Med Chem Lett 15: 5095-9 (2005)
Article DOI: 10.1016/j.bmcl.2005.06.083 BindingDB Entry DOI: 10.7270/Q2JW8DFC |
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 14
(Homo sapiens (Human)) | BDBM50172922
(4-[6-(2-Chloro-phenylamino)-1H-indazol-3-yl]-benzo...)Show SMILES OC(=O)c1ccc(cc1)-c1n[nH]c2cc(Nc3ccccc3Cl)ccc12 Show InChI InChI=1S/C20H14ClN3O2/c21-16-3-1-2-4-17(16)22-14-9-10-15-18(11-14)23-24-19(15)12-5-7-13(8-6-12)20(25)26/h1-11,22H,(H,23,24)(H,25,26) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 13 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D Södertälje
Curated by ChEMBL
| Assay Description Inhibitory concentration against Mitogen-activated protein kinase p38 alpha |
Bioorg Med Chem Lett 15: 5095-9 (2005)
Article DOI: 10.1016/j.bmcl.2005.06.083 BindingDB Entry DOI: 10.7270/Q2JW8DFC |
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 14
(Homo sapiens (Human)) | BDBM50172923
(3-[6-(2-Chloro-phenylamino)-1H-indazol-3-yl]-N-(2-...)Show SMILES CN(C)CCNC(=O)c1cccc(c1)-c1n[nH]c2cc(Nc3ccccc3Cl)ccc12 Show InChI InChI=1S/C24H24ClN5O/c1-30(2)13-12-26-24(31)17-7-5-6-16(14-17)23-19-11-10-18(15-22(19)28-29-23)27-21-9-4-3-8-20(21)25/h3-11,14-15,27H,12-13H2,1-2H3,(H,26,31)(H,28,29) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 16 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D Södertälje
Curated by ChEMBL
| Assay Description Inhibitory concentration against Mitogen-activated protein kinase p38 alpha |
Bioorg Med Chem Lett 15: 5095-9 (2005)
Article DOI: 10.1016/j.bmcl.2005.06.083 BindingDB Entry DOI: 10.7270/Q2JW8DFC |
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 14
(Homo sapiens (Human)) | BDBM50172918
((2-Chloro-phenyl)-(3-phenyl-1H-indazol-6-yl)-amine...)Show InChI InChI=1S/C19H14ClN3/c20-16-8-4-5-9-17(16)21-14-10-11-15-18(12-14)22-23-19(15)13-6-2-1-3-7-13/h1-12,21H,(H,22,23) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 18 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D Södertälje
Curated by ChEMBL
| Assay Description Inhibitory concentration against Mitogen-activated protein kinase p38 alpha |
Bioorg Med Chem Lett 15: 5095-9 (2005)
Article DOI: 10.1016/j.bmcl.2005.06.083 BindingDB Entry DOI: 10.7270/Q2JW8DFC |
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 10
(Homo sapiens (Human)) | BDBM50172923
(3-[6-(2-Chloro-phenylamino)-1H-indazol-3-yl]-N-(2-...)Show SMILES CN(C)CCNC(=O)c1cccc(c1)-c1n[nH]c2cc(Nc3ccccc3Cl)ccc12 Show InChI InChI=1S/C24H24ClN5O/c1-30(2)13-12-26-24(31)17-7-5-6-16(14-17)23-19-11-10-18(15-22(19)28-29-23)27-21-9-4-3-8-20(21)25/h3-11,14-15,27H,12-13H2,1-2H3,(H,26,31)(H,28,29) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 21 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D Södertälje
Curated by ChEMBL
| Assay Description Inhibitory concentration against c-Jun N-terminal kinase 3 |
Bioorg Med Chem Lett 15: 5095-9 (2005)
Article DOI: 10.1016/j.bmcl.2005.06.083 BindingDB Entry DOI: 10.7270/Q2JW8DFC |
More data for this Ligand-Target Pair | |
Metabotropic glutamate receptor 5
(Homo sapiens (Human)) | BDBM50084137
(2-Methyl-6-(phenylethynyl)pyridine | 2-Methyl-6-ph...)Show InChI InChI=1S/C14H11N/c1-12-6-5-9-14(15-12)11-10-13-7-3-2-4-8-13/h2-9H,1H3 | PDB MMDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL MCE PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 22 | n/a | n/a | n/a | n/a | n/a | n/a |
NPS-Pharmaceuticals
Curated by ChEMBL
| Assay Description Inhibition of glutamate-induced calcium influx in human mGluR5d by FLIPR |
Bioorg Med Chem Lett 16: 2467-9 (2006)
Article DOI: 10.1016/j.bmcl.2006.01.100 BindingDB Entry DOI: 10.7270/Q22Z1544 |
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 14
(Homo sapiens (Human)) | BDBM50172927
(3-[6-(2-Chloro-phenylamino)-1H-indazol-3-yl]-benzo...)Show SMILES OC(=O)c1cccc(c1)-c1n[nH]c2cc(Nc3ccccc3Cl)ccc12 Show InChI InChI=1S/C20H14ClN3O2/c21-16-6-1-2-7-17(16)22-14-8-9-15-18(11-14)23-24-19(15)12-4-3-5-13(10-12)20(25)26/h1-11,22H,(H,23,24)(H,25,26) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 24 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D Södertälje
Curated by ChEMBL
| Assay Description Inhibitory concentration against Mitogen-activated protein kinase p38 alpha |
Bioorg Med Chem Lett 15: 5095-9 (2005)
Article DOI: 10.1016/j.bmcl.2005.06.083 BindingDB Entry DOI: 10.7270/Q2JW8DFC |
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 14
(Homo sapiens (Human)) | BDBM50172925
(CHEMBL383177 | N,3-diphenyl-1H-indazol-6-amine | P...)Show InChI InChI=1S/C19H15N3/c1-3-7-14(8-4-1)19-17-12-11-16(13-18(17)21-22-19)20-15-9-5-2-6-10-15/h1-13,20H,(H,21,22) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 30 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D Södertälje
Curated by ChEMBL
| Assay Description Inhibitory concentration against Mitogen-activated protein kinase p38 alpha |
Bioorg Med Chem Lett 15: 5095-9 (2005)
Article DOI: 10.1016/j.bmcl.2005.06.083 BindingDB Entry DOI: 10.7270/Q2JW8DFC |
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 10
(Homo sapiens (Human)) | BDBM50172918
((2-Chloro-phenyl)-(3-phenyl-1H-indazol-6-yl)-amine...)Show InChI InChI=1S/C19H14ClN3/c20-16-8-4-5-9-17(16)21-14-10-11-15-18(12-14)22-23-19(15)13-6-2-1-3-7-13/h1-12,21H,(H,22,23) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 30 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D Södertälje
Curated by ChEMBL
| Assay Description Inhibitory concentration against c-Jun N-terminal kinase 3 |
Bioorg Med Chem Lett 15: 5095-9 (2005)
Article DOI: 10.1016/j.bmcl.2005.06.083 BindingDB Entry DOI: 10.7270/Q2JW8DFC |
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 10
(Homo sapiens (Human)) | BDBM50172922
(4-[6-(2-Chloro-phenylamino)-1H-indazol-3-yl]-benzo...)Show SMILES OC(=O)c1ccc(cc1)-c1n[nH]c2cc(Nc3ccccc3Cl)ccc12 Show InChI InChI=1S/C20H14ClN3O2/c21-16-3-1-2-4-17(16)22-14-9-10-15-18(11-14)23-24-19(15)12-5-7-13(8-6-12)20(25)26/h1-11,22H,(H,23,24)(H,25,26) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 32 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D Södertälje
Curated by ChEMBL
| Assay Description Inhibitory concentration against c-Jun N-terminal kinase 3 |
Bioorg Med Chem Lett 15: 5095-9 (2005)
Article DOI: 10.1016/j.bmcl.2005.06.083 BindingDB Entry DOI: 10.7270/Q2JW8DFC |
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 8
(Homo sapiens (Human)) | BDBM50211306
(4-(6-(2-chlorophenylamino)-1H-indazol-3-yl)-N-(2-(...)Show SMILES CN(C)CCNC(=O)c1ccc(cc1)-c1n[nH]c2cc(Nc3ccccc3Cl)ccc12 Show InChI InChI=1S/C24H24ClN5O/c1-30(2)14-13-26-24(31)17-9-7-16(8-10-17)23-19-12-11-18(15-22(19)28-29-23)27-21-6-4-3-5-20(21)25/h3-12,15,27H,13-14H2,1-2H3,(H,26,31)(H,28,29) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 45 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D Södertälje
Curated by ChEMBL
| Assay Description Inhibitory concentration against c-Jun N-terminal kinase 1 |
Bioorg Med Chem Lett 15: 5095-9 (2005)
Article DOI: 10.1016/j.bmcl.2005.06.083 BindingDB Entry DOI: 10.7270/Q2JW8DFC |
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 14
(Homo sapiens (Human)) | BDBM50211303
((2-Methoxy-phenyl)-(3-phenyl-1H-indazol-6-yl)-amin...)Show InChI InChI=1S/C20H17N3O/c1-24-19-10-6-5-9-17(19)21-15-11-12-16-18(13-15)22-23-20(16)14-7-3-2-4-8-14/h2-13,21H,1H3,(H,22,23) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 46 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D Södertälje
Curated by ChEMBL
| Assay Description Inhibitory concentration against Mitogen-activated protein kinase p38 alpha |
Bioorg Med Chem Lett 15: 5095-9 (2005)
Article DOI: 10.1016/j.bmcl.2005.06.083 BindingDB Entry DOI: 10.7270/Q2JW8DFC |
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 10
(Homo sapiens (Human)) | BDBM50172925
(CHEMBL383177 | N,3-diphenyl-1H-indazol-6-amine | P...)Show InChI InChI=1S/C19H15N3/c1-3-7-14(8-4-1)19-17-12-11-16(13-18(17)21-22-19)20-15-9-5-2-6-10-15/h1-13,20H,(H,21,22) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 48 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D Södertälje
Curated by ChEMBL
| Assay Description Inhibitory concentration against c-Jun N-terminal kinase 3 |
Bioorg Med Chem Lett 15: 5095-9 (2005)
Article DOI: 10.1016/j.bmcl.2005.06.083 BindingDB Entry DOI: 10.7270/Q2JW8DFC |
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 8
(Homo sapiens (Human)) | BDBM50172927
(3-[6-(2-Chloro-phenylamino)-1H-indazol-3-yl]-benzo...)Show SMILES OC(=O)c1cccc(c1)-c1n[nH]c2cc(Nc3ccccc3Cl)ccc12 Show InChI InChI=1S/C20H14ClN3O2/c21-16-6-1-2-7-17(16)22-14-8-9-15-18(11-14)23-24-19(15)12-4-3-5-13(10-12)20(25)26/h1-11,22H,(H,23,24)(H,25,26) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 61 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D Södertälje
Curated by ChEMBL
| Assay Description Inhibitory concentration against c-Jun N-terminal kinase 1 |
Bioorg Med Chem Lett 15: 5095-9 (2005)
Article DOI: 10.1016/j.bmcl.2005.06.083 BindingDB Entry DOI: 10.7270/Q2JW8DFC |
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 8
(Homo sapiens (Human)) | BDBM50172920
(3-(6-(2-chlorophenylamino)-1H-indazol-3-yl)-N-(pip...)Show SMILES Clc1ccccc1Nc1ccc2c(n[nH]c2c1)-c1cccc(c1)C(=O)NC1CCNCC1 Show InChI InChI=1S/C25H24ClN5O/c26-21-6-1-2-7-22(21)28-19-8-9-20-23(15-19)30-31-24(20)16-4-3-5-17(14-16)25(32)29-18-10-12-27-13-11-18/h1-9,14-15,18,27-28H,10-13H2,(H,29,32)(H,30,31) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 71 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D Södertälje
Curated by ChEMBL
| Assay Description Inhibitory concentration against c-Jun N-terminal kinase 1 |
Bioorg Med Chem Lett 15: 5095-9 (2005)
Article DOI: 10.1016/j.bmcl.2005.06.083 BindingDB Entry DOI: 10.7270/Q2JW8DFC |
More data for this Ligand-Target Pair | |
Metabotropic glutamate receptor 5
(Homo sapiens (Human)) | BDBM50182823
(4-(3,4-dichlorophenylthio)-2-(5-fluoropyridin-2-yl...)Show InChI InChI=1S/C15H8Cl2FN3S/c16-11-3-2-10(7-12(11)17)22-14-5-6-19-15(21-14)13-4-1-9(18)8-20-13/h1-8H | PDB MMDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 80 | n/a | n/a | n/a | n/a | n/a | n/a |
NPS-Pharmaceuticals
Curated by ChEMBL
| Assay Description Inhibition of glutamate-induced calcium influx in human mGluR5d by FLIPR |
Bioorg Med Chem Lett 16: 2467-9 (2006)
Article DOI: 10.1016/j.bmcl.2006.01.100 BindingDB Entry DOI: 10.7270/Q22Z1544 |
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 8
(Homo sapiens (Human)) | BDBM50172919
(3-[6-(2-Chloro-phenylamino)-1H-indazol-3-yl]-benza...)Show SMILES NC(=O)c1cccc(c1)-c1n[nH]c2cc(Nc3ccccc3Cl)ccc12 Show InChI InChI=1S/C20H15ClN4O/c21-16-6-1-2-7-17(16)23-14-8-9-15-18(11-14)24-25-19(15)12-4-3-5-13(10-12)20(22)26/h1-11,23H,(H2,22,26)(H,24,25) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 81 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D Södertälje
Curated by ChEMBL
| Assay Description Inhibitory concentration against c-Jun N-terminal kinase 1 |
Bioorg Med Chem Lett 15: 5095-9 (2005)
Article DOI: 10.1016/j.bmcl.2005.06.083 BindingDB Entry DOI: 10.7270/Q2JW8DFC |
More data for this Ligand-Target Pair | |
Metabotropic glutamate receptor 5
(Homo sapiens (Human)) | BDBM50182811
(4-(3,4-dichlorophenylthio)-2-(pyridin-2-yl)pyrimid...)Show InChI InChI=1S/C15H9Cl2N3S/c16-11-5-4-10(9-12(11)17)21-14-6-8-19-15(20-14)13-3-1-2-7-18-13/h1-9H | PDB MMDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 90 | n/a | n/a | n/a | n/a | n/a | n/a |
NPS-Pharmaceuticals
Curated by ChEMBL
| Assay Description Inhibition of glutamate-induced calcium influx in human mGluR5d by FLIPR |
Bioorg Med Chem Lett 16: 2467-9 (2006)
Article DOI: 10.1016/j.bmcl.2006.01.100 BindingDB Entry DOI: 10.7270/Q22Z1544 |
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 10
(Homo sapiens (Human)) | BDBM50211303
((2-Methoxy-phenyl)-(3-phenyl-1H-indazol-6-yl)-amin...)Show InChI InChI=1S/C20H17N3O/c1-24-19-10-6-5-9-17(19)21-15-11-12-16-18(13-15)22-23-20(16)14-7-3-2-4-8-14/h2-13,21H,1H3,(H,22,23) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 202 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D Södertälje
Curated by ChEMBL
| Assay Description Inhibitory concentration against c-Jun N-terminal kinase 3 |
Bioorg Med Chem Lett 15: 5095-9 (2005)
Article DOI: 10.1016/j.bmcl.2005.06.083 BindingDB Entry DOI: 10.7270/Q2JW8DFC |
More data for this Ligand-Target Pair | |
Metabotropic glutamate receptor 5
(Homo sapiens (Human)) | BDBM50182813
(2-(pyridin-2-yl)-4-(4-(trifluoromethyl)phenylthio)...)Show InChI InChI=1S/C16H10F3N3S/c17-16(18,19)11-4-6-12(7-5-11)23-14-8-10-21-15(22-14)13-3-1-2-9-20-13/h1-10H | PDB MMDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 210 | n/a | n/a | n/a | n/a | n/a | n/a |
NPS-Pharmaceuticals
Curated by ChEMBL
| Assay Description Inhibition of glutamate-induced calcium influx in human mGluR5d by FLIPR |
Bioorg Med Chem Lett 16: 2467-9 (2006)
Article DOI: 10.1016/j.bmcl.2006.01.100 BindingDB Entry DOI: 10.7270/Q22Z1544 |
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 8
(Homo sapiens (Human)) | BDBM50172921
(3-[6-(2-Chloro-phenylamino)-1H-indazol-3-yl]-N-(3-...)Show SMILES Clc1ccccc1Nc1ccc2c(n[nH]c2c1)-c1cccc(c1)C(=O)NCCCN1CCOCC1 Show InChI InChI=1S/C27H28ClN5O2/c28-23-7-1-2-8-24(23)30-21-9-10-22-25(18-21)31-32-26(22)19-5-3-6-20(17-19)27(34)29-11-4-12-33-13-15-35-16-14-33/h1-3,5-10,17-18,30H,4,11-16H2,(H,29,34)(H,31,32) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 228 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D Södertälje
Curated by ChEMBL
| Assay Description Inhibitory concentration against c-Jun N-terminal kinase 1 |
Bioorg Med Chem Lett 15: 5095-9 (2005)
Article DOI: 10.1016/j.bmcl.2005.06.083 BindingDB Entry DOI: 10.7270/Q2JW8DFC |
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 8
(Homo sapiens (Human)) | BDBM50172922
(4-[6-(2-Chloro-phenylamino)-1H-indazol-3-yl]-benzo...)Show SMILES OC(=O)c1ccc(cc1)-c1n[nH]c2cc(Nc3ccccc3Cl)ccc12 Show InChI InChI=1S/C20H14ClN3O2/c21-16-3-1-2-4-17(16)22-14-9-10-15-18(11-14)23-24-19(15)12-5-7-13(8-6-12)20(25)26/h1-11,22H,(H,23,24)(H,25,26) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 246 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D Södertälje
Curated by ChEMBL
| Assay Description Inhibitory concentration against c-Jun N-terminal kinase 1 |
Bioorg Med Chem Lett 15: 5095-9 (2005)
Article DOI: 10.1016/j.bmcl.2005.06.083 BindingDB Entry DOI: 10.7270/Q2JW8DFC |
More data for this Ligand-Target Pair | |
Metabotropic glutamate receptor 5
(Homo sapiens (Human)) | BDBM50182822
(4-(4-chlorophenylthio)-2-(pyridin-2-yl)pyrimidine ...)Show InChI InChI=1S/C15H10ClN3S/c16-11-4-6-12(7-5-11)20-14-8-10-18-15(19-14)13-3-1-2-9-17-13/h1-10H | PDB MMDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 320 | n/a | n/a | n/a | n/a | n/a | n/a |
NPS-Pharmaceuticals
Curated by ChEMBL
| Assay Description Inhibition of glutamate-induced calcium influx in human mGluR5d by FLIPR |
Bioorg Med Chem Lett 16: 2467-9 (2006)
Article DOI: 10.1016/j.bmcl.2006.01.100 BindingDB Entry DOI: 10.7270/Q22Z1544 |
More data for this Ligand-Target Pair | |
Cyclin-dependent kinase 5 activator 1
(Homo sapiens (Human)) | BDBM50390639
(CHEMBL2069712)Show InChI InChI=1S/C11H7FN2O2S3/c12-7-1-2-8-9(4-7)18-11(14-8)6-3-10(17-5-6)19(13,15)16/h1-5H,(H2,13,15,16) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 331 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description Inhibition of human recombinant Cdk5/p25 incubated for 15 mins by scintillation proximity assay |
Bioorg Med Chem Lett 22: 5919-23 (2012)
Article DOI: 10.1016/j.bmcl.2012.07.068 BindingDB Entry DOI: 10.7270/Q2G73FTN |
More data for this Ligand-Target Pair | |
Cyclin-dependent kinase 5 activator 1
(Homo sapiens (Human)) | BDBM50390640
(CHEMBL2069713)Show InChI InChI=1S/C11H7ClN2O2S3/c12-7-1-2-8-9(4-7)18-11(14-8)6-3-10(17-5-6)19(13,15)16/h1-5H,(H2,13,15,16) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 355 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description Inhibition of human recombinant Cdk5/p25 incubated for 15 mins by scintillation proximity assay |
Bioorg Med Chem Lett 22: 5919-23 (2012)
Article DOI: 10.1016/j.bmcl.2012.07.068 BindingDB Entry DOI: 10.7270/Q2G73FTN |
More data for this Ligand-Target Pair | |
Metabotropic glutamate receptor 5
(Homo sapiens (Human)) | BDBM50182819
(4-(3,4-dichlorophenylthio)-2-(6-methylpyridin-2-yl...)Show InChI InChI=1S/C16H11Cl2N3S/c1-10-3-2-4-14(20-10)16-19-8-7-15(21-16)22-11-5-6-12(17)13(18)9-11/h2-9H,1H3 | PDB MMDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 390 | n/a | n/a | n/a | n/a | n/a | n/a |
NPS-Pharmaceuticals
Curated by ChEMBL
| Assay Description Inhibition of glutamate-induced calcium influx in human mGluR5d by FLIPR |
Bioorg Med Chem Lett 16: 2467-9 (2006)
Article DOI: 10.1016/j.bmcl.2006.01.100 BindingDB Entry DOI: 10.7270/Q22Z1544 |
More data for this Ligand-Target Pair | |
Metabotropic glutamate receptor 5
(Homo sapiens (Human)) | BDBM50182816
(2-(pyridin-2-yl)-4-(3-(trifluoromethyl)phenylthio)...)Show InChI InChI=1S/C16H10F3N3S/c17-16(18,19)11-4-3-5-12(10-11)23-14-7-9-21-15(22-14)13-6-1-2-8-20-13/h1-10H | PDB MMDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
NPS-Pharmaceuticals
Curated by ChEMBL
| Assay Description Inhibition of glutamate-induced calcium influx in human mGluR5d by FLIPR |
Bioorg Med Chem Lett 16: 2467-9 (2006)
Article DOI: 10.1016/j.bmcl.2006.01.100 BindingDB Entry DOI: 10.7270/Q22Z1544 |
More data for this Ligand-Target Pair | |
Cyclin-dependent kinase 5 activator 1
(Homo sapiens (Human)) | BDBM50390638
(CHEMBL2069711)Show InChI InChI=1S/C11H8N2O2S3/c12-18(14,15)10-5-7(6-16-10)11-13-8-3-1-2-4-9(8)17-11/h1-6H,(H2,12,14,15) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL MMDB PC cid PC sid PDB UniChem
Similars
| PDB Article PubMed
| n/a | n/a | 551 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description Inhibition of human recombinant Cdk5/p25 incubated for 15 mins by scintillation proximity assay |
Bioorg Med Chem Lett 22: 5919-23 (2012)
Article DOI: 10.1016/j.bmcl.2012.07.068 BindingDB Entry DOI: 10.7270/Q2G73FTN |
More data for this Ligand-Target Pair | 3D Structure (crystal) |
Metabotropic glutamate receptor 5
(Homo sapiens (Human)) | BDBM50182809
(4-(3-chlorophenylthio)-2-(pyridin-2-yl)pyrimidine ...)Show InChI InChI=1S/C15H10ClN3S/c16-11-4-3-5-12(10-11)20-14-7-9-18-15(19-14)13-6-1-2-8-17-13/h1-10H | PDB MMDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 620 | n/a | n/a | n/a | n/a | n/a | n/a |
NPS-Pharmaceuticals
Curated by ChEMBL
| Assay Description Inhibition of glutamate-induced calcium influx in human mGluR5d by FLIPR |
Bioorg Med Chem Lett 16: 2467-9 (2006)
Article DOI: 10.1016/j.bmcl.2006.01.100 BindingDB Entry DOI: 10.7270/Q22Z1544 |
More data for this Ligand-Target Pair | |
Cyclin-dependent kinase 5 activator 1
(Homo sapiens (Human)) | BDBM50390653
(CHEMBL2069727)Show InChI InChI=1S/C11H6ClFN2O2S3/c12-9-6(13)1-2-7-10(9)19-11(15-7)5-3-8(18-4-5)20(14,16)17/h1-4H,(H2,14,16,17) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 672 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description Inhibition of human recombinant Cdk5/p25 incubated for 15 mins by scintillation proximity assay |
Bioorg Med Chem Lett 22: 5919-23 (2012)
Article DOI: 10.1016/j.bmcl.2012.07.068 BindingDB Entry DOI: 10.7270/Q2G73FTN |
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 8
(Homo sapiens (Human)) | BDBM50172923
(3-[6-(2-Chloro-phenylamino)-1H-indazol-3-yl]-N-(2-...)Show SMILES CN(C)CCNC(=O)c1cccc(c1)-c1n[nH]c2cc(Nc3ccccc3Cl)ccc12 Show InChI InChI=1S/C24H24ClN5O/c1-30(2)13-12-26-24(31)17-7-5-6-16(14-17)23-19-11-10-18(15-22(19)28-29-23)27-21-9-4-3-8-20(21)25/h3-11,14-15,27H,12-13H2,1-2H3,(H,26,31)(H,28,29) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 698 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D Södertälje
Curated by ChEMBL
| Assay Description Inhibitory concentration against c-Jun N-terminal kinase 1 |
Bioorg Med Chem Lett 15: 5095-9 (2005)
Article DOI: 10.1016/j.bmcl.2005.06.083 BindingDB Entry DOI: 10.7270/Q2JW8DFC |
More data for this Ligand-Target Pair | |
Metabotropic glutamate receptor 5
(Homo sapiens (Human)) | BDBM50182814
(4-(4-chlorophenylthio)-6-methyl-2-(pyridin-2-yl)py...)Show InChI InChI=1S/C16H12ClN3S/c1-11-10-15(21-13-7-5-12(17)6-8-13)20-16(19-11)14-4-2-3-9-18-14/h2-10H,1H3 | PDB MMDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 1.25E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
NPS-Pharmaceuticals
Curated by ChEMBL
| Assay Description Inhibition of glutamate-induced calcium influx in human mGluR5d by FLIPR |
Bioorg Med Chem Lett 16: 2467-9 (2006)
Article DOI: 10.1016/j.bmcl.2006.01.100 BindingDB Entry DOI: 10.7270/Q22Z1544 |
More data for this Ligand-Target Pair | |
Cyclin-dependent kinase 5 activator 1
(Homo sapiens (Human)) | BDBM50390641
(CHEMBL2069714)Show InChI InChI=1S/C12H10N2O2S3/c1-7-2-3-9-10(4-7)18-12(14-9)8-5-11(17-6-8)19(13,15)16/h2-6H,1H3,(H2,13,15,16) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 1.26E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description Inhibition of human recombinant Cdk5/p25 incubated for 15 mins by scintillation proximity assay |
Bioorg Med Chem Lett 22: 5919-23 (2012)
Article DOI: 10.1016/j.bmcl.2012.07.068 BindingDB Entry DOI: 10.7270/Q2G73FTN |
More data for this Ligand-Target Pair | |
Cyclin-dependent kinase 5 activator 1
(Homo sapiens (Human)) | BDBM50390642
(CHEMBL2069715)Show SMILES NS(=O)(=O)c1cc(cs1)-c1nc2ccc(cc2s1)[N+]([O-])=O Show InChI InChI=1S/C11H7N3O4S3/c12-21(17,18)10-3-6(5-19-10)11-13-8-2-1-7(14(15)16)4-9(8)20-11/h1-5H,(H2,12,17,18) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 1.27E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description Inhibition of human recombinant Cdk5/p25 incubated for 15 mins by scintillation proximity assay |
Bioorg Med Chem Lett 22: 5919-23 (2012)
Article DOI: 10.1016/j.bmcl.2012.07.068 BindingDB Entry DOI: 10.7270/Q2G73FTN |
More data for this Ligand-Target Pair | |
Metabotropic glutamate receptor 5
(Homo sapiens (Human)) | BDBM50182821
(4-(3,4-difluorophenylthio)-2-(pyridin-2-yl)pyrimid...)Show InChI InChI=1S/C15H9F2N3S/c16-11-5-4-10(9-12(11)17)21-14-6-8-19-15(20-14)13-3-1-2-7-18-13/h1-9H | PDB MMDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 1.52E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
NPS-Pharmaceuticals
Curated by ChEMBL
| Assay Description Inhibition of glutamate-induced calcium influx in human mGluR5d by FLIPR |
Bioorg Med Chem Lett 16: 2467-9 (2006)
Article DOI: 10.1016/j.bmcl.2006.01.100 BindingDB Entry DOI: 10.7270/Q22Z1544 |
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 8
(Homo sapiens (Human)) | BDBM50211303
((2-Methoxy-phenyl)-(3-phenyl-1H-indazol-6-yl)-amin...)Show InChI InChI=1S/C20H17N3O/c1-24-19-10-6-5-9-17(19)21-15-11-12-16-18(13-15)22-23-20(16)14-7-3-2-4-8-14/h2-13,21H,1H3,(H,22,23) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 1.60E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D Södertälje
Curated by ChEMBL
| Assay Description Inhibitory concentration against c-Jun N-terminal kinase 1 |
Bioorg Med Chem Lett 15: 5095-9 (2005)
Article DOI: 10.1016/j.bmcl.2005.06.083 BindingDB Entry DOI: 10.7270/Q2JW8DFC |
More data for this Ligand-Target Pair | |
Cyclin-dependent kinase 5 activator 1
(Homo sapiens (Human)) | BDBM50390645
(CHEMBL2069719)Show InChI InChI=1S/C14H9N3O2S4/c18-23(19,17-14-15-5-6-20-14)12-7-9(8-21-12)13-16-10-3-1-2-4-11(10)22-13/h1-8H,(H,15,17) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 1.76E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description Inhibition of human recombinant Cdk5/p25 incubated for 15 mins by scintillation proximity assay |
Bioorg Med Chem Lett 22: 5919-23 (2012)
Article DOI: 10.1016/j.bmcl.2012.07.068 BindingDB Entry DOI: 10.7270/Q2G73FTN |
More data for this Ligand-Target Pair | |
Metabotropic glutamate receptor 5
(Homo sapiens (Human)) | BDBM50182815
(2-(pyridin-2-yl)-4-(m-tolylthio)pyrimidine | CHEMB...)Show InChI InChI=1S/C16H13N3S/c1-12-5-4-6-13(11-12)20-15-8-10-18-16(19-15)14-7-2-3-9-17-14/h2-11H,1H3 | PDB MMDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 2.30E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
NPS-Pharmaceuticals
Curated by ChEMBL
| Assay Description Inhibition of glutamate-induced calcium influx in human mGluR5d by FLIPR |
Bioorg Med Chem Lett 16: 2467-9 (2006)
Article DOI: 10.1016/j.bmcl.2006.01.100 BindingDB Entry DOI: 10.7270/Q22Z1544 |
More data for this Ligand-Target Pair | |
Metabotropic glutamate receptor 5
(Homo sapiens (Human)) | BDBM50182812
(2-(4-(3,4-dichlorophenylthio)pyridin-2-yl)pyridine...)Show InChI InChI=1S/C16H10Cl2N2S/c17-13-5-4-11(9-14(13)18)21-12-6-8-20-16(10-12)15-3-1-2-7-19-15/h1-10H | PDB MMDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 2.37E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
NPS-Pharmaceuticals
Curated by ChEMBL
| Assay Description Inhibition of glutamate-induced calcium influx in human mGluR5d by FLIPR |
Bioorg Med Chem Lett 16: 2467-9 (2006)
Article DOI: 10.1016/j.bmcl.2006.01.100 BindingDB Entry DOI: 10.7270/Q22Z1544 |
More data for this Ligand-Target Pair | |
Metabotropic glutamate receptor 5
(Homo sapiens (Human)) | BDBM50182817
(4-(3-bromophenylthio)-2-(pyridin-2-yl)pyrimidine |...)Show InChI InChI=1S/C15H10BrN3S/c16-11-4-3-5-12(10-11)20-14-7-9-18-15(19-14)13-6-1-2-8-17-13/h1-10H | PDB MMDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 2.86E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
NPS-Pharmaceuticals
Curated by ChEMBL
| Assay Description Inhibition of glutamate-induced calcium influx in human mGluR5d by FLIPR |
Bioorg Med Chem Lett 16: 2467-9 (2006)
Article DOI: 10.1016/j.bmcl.2006.01.100 BindingDB Entry DOI: 10.7270/Q22Z1544 |
More data for this Ligand-Target Pair | |
Metabotropic glutamate receptor 5
(Homo sapiens (Human)) | BDBM50182805
((4-chlorophenyl)(2-(pyridin-2-yl)pyrimidin-4-yl)me...)Show InChI InChI=1S/C16H12ClN3O/c17-12-6-4-11(5-7-12)15(21)13-8-10-19-16(20-13)14-3-1-2-9-18-14/h1-10,15,21H | PDB MMDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | >3.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
NPS-Pharmaceuticals
Curated by ChEMBL
| Assay Description Inhibition of glutamate-induced calcium influx in human mGluR5d by FLIPR |
Bioorg Med Chem Lett 16: 2467-9 (2006)
Article DOI: 10.1016/j.bmcl.2006.01.100 BindingDB Entry DOI: 10.7270/Q22Z1544 |
More data for this Ligand-Target Pair | |
Cyclin-dependent kinase 5 activator 1
(Homo sapiens (Human)) | BDBM50390640
(CHEMBL2069713)Show InChI InChI=1S/C11H7ClN2O2S3/c12-7-1-2-8-9(4-7)18-11(14-8)6-3-10(17-5-6)19(13,15)16/h1-5H,(H2,13,15,16) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 4.36E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description Inhibition of Cdk5/p25-mediated myosin heavy chain phosphorylation in HEK293 cells |
Bioorg Med Chem Lett 22: 5919-23 (2012)
Article DOI: 10.1016/j.bmcl.2012.07.068 BindingDB Entry DOI: 10.7270/Q2G73FTN |
More data for this Ligand-Target Pair | |